Bicon Pharma Lands $250 Million in PE Capital from PAG Asia

Published: Feb 28, 2012

February 28, 2012 -- Bicon Pharma, a Xian maker of APIs and finished drugs, received a massive $250 million in fresh capital from private equity fund PAG Asia Capital. PAG spent last year amassing its $1.7 billion war chest and is now deploying funds. Bicon said the investment will be used to make acquisitions and to fund a large complex in Jiangsu province that includes space for R&D as well as manufacturing. More details....

Back to news